Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M

K-Number: K031177 · 2003-06-19

ApplicantAxis-Shield Diagnostics, Ltd.
Decision Date2003-06-19
Product CodeMSV
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M is the device name listed in this FDA 510(k) record. The listed applicant is Axis-Shield Diagnostics, Ltd.. It received FDA 510(k) clearance on 2003-06-19 under 510(k) number K031177. The device is classified under product code MSV. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M?

DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M is a medical device that received FDA 510(k) clearance on 2003-06-19. The listed applicant is Axis-Shield Diagnostics, Ltd.. The 510(k) number is K031177.

When did DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M receive FDA 510(k) clearance?

DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M received FDA 510(k) clearance on 2003-06-19, under 510(k) number K031177.

Who is the listed applicant for DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M?

The FDA 510(k) record lists Axis-Shield Diagnostics, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M?

The FDA product code for DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M is MSV.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Axis-Shield Diagnostics, Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253539Alere NT-proBNP for Alinity iK241176Alere NT-proBNP for Alinity i Reagent KitK233541ARCHITECT Active-B12 (Holotranscobalamin)K172133ADVIA Centaur Active-B12 (Holotranscobalamin) (AB12) AssayK121946AXIS-SHIELD ACVTIVE-B12K121842ARCHITECT HBA1C, ARCHITECT HBA1C, AND ARCHITECT HBA1C

View all 24 devices →

Related Devices (Code: MSV)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K243979Aptiva APS IgA ReagentInova Diagnostics, Inc.K181329EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA ImmunoassayPhadia ABK162788ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISAImmco Diagnostics, Inc.K112414ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAYPhadia US, Inc.K091556HEMOSIL ACUSTAR ANTI-B2 GLYCOPROTEIN-I; IGG, IGM, IGG CONTROLS, IGM CONTROLSInstrumentation Laboratory COK092757THERATEST EL-BETA2GPI (IGM-IGG-IGA), THERATEST EL--BETA2GPI SCRThera-Test Laboratories, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑